M. Alan Brookhart, PhD

Professor
Duke University
Duke University
Chapel Hill, North Carolina, United States

Amgen (Consultant/Advisory Board)Atara Biosciences (Consultant/Advisory Board)Brigham and Women's Hospital (Consultant/Advisory Board)Kite/Gilead (Consultant/Advisory Board)Target RWE (Consultant/Advisory Board)Vertex (Consultant/Advisory Board)

Presentation(s):

• Negative Control Outcomes to Assess the Comparability of Biologics versus Small-molecule Therapeutics for Osteoporosis: Considerations for Differential Non-adherence

  Friday, August 26, 2022
  5:30 PM – 5:45 PM CEST

• Influence of Incomplete Death Information on Cumulative Risk Estimates in United States Claims Data

  Friday, August 26, 2022
  5:15 PM – 5:30 PM CEST

• Risk Factors for Mortality and Intensive Care Requirements Among Pediatric Patients Hospitalized with COVID-19 in the United States

  Saturday, August 27, 2022
  8:15 AM – 8:30 AM CEST

• Fracture Risk Estimation in Post-menopausal Women: A Comparison of Machine Learning Methods and Software Systems

  Saturday, August 27, 2022
  1:15 PM – 1:30 PM CEST

• The Effect of Remdesivir for The Treatment of COVID-19 on Mortality Among Hospitalized Patients

  Sunday, August 28, 2022
  8:30 AM – 10:00 AM CEST